2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 82.347 | 104.748 | 94.433 | 74.309 | 74.646 | 103.055 | 176.497 | 166.373 | 160.112 | 217.534 |
Total Income - EUR | 89.693 | 108.075 | 96.848 | 75.204 | 75.071 | 122.573 | 177.092 | 168.834 | 165.849 | 223.755 |
Total Expenses - EUR | 88.937 | 108.560 | 102.402 | 88.589 | 90.048 | 121.024 | 175.265 | 166.672 | 163.294 | 219.770 |
Gross Profit/Loss - EUR | 757 | -485 | -5.554 | -13.385 | -14.977 | 1.548 | 1.827 | 2.162 | 2.555 | 3.985 |
Net Profit/Loss - EUR | 757 | -485 | -5.554 | -14.137 | -15.690 | 322 | 356 | 474 | 896 | 1.748 |
Employees | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Check the financial reports for the company - Farmacia Ultramed Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 644 | 553 | 451 | 341 | 250 | 1.378 | 1.173 | 993 | 890 | 781 |
Current Assets | 46.342 | 56.625 | 59.297 | 38.787 | 29.637 | 44.266 | 42.829 | 39.578 | 34.345 | 68.484 |
Inventories | 28.520 | 16.963 | 13.653 | 13.663 | 12.046 | 28.869 | 34.702 | 22.923 | 20.982 | 35.694 |
Receivables | 12.020 | 20.805 | 3.168 | 7.743 | 8.681 | 3.438 | 4.022 | 3.640 | 4.322 | 18.682 |
Cash | 5.801 | 18.857 | 42.475 | 17.382 | 8.910 | 11.959 | 4.105 | 13.015 | 9.041 | 14.108 |
Shareholders Funds | -8.018 | -8.570 | -14.037 | -27.936 | -43.114 | -41.956 | -40.805 | -39.426 | -38.652 | -36.787 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 57.680 | 67.877 | 75.684 | 68.693 | 74.150 | 89.190 | 86.286 | 81.129 | 74.479 | 107.874 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Farmacia Ultramed Srl